Abstract
The management of patients with cervical node metastasis (CNM) from carcinoma of unknown primary (CUP) often includes several radiographic studies and invasive procedures that are only successful in detecting an occult primary tumour in less than 25% of the cases. In this prospective study we have assessed the role of total body positron emission tomography (PET) using an 18-F-fluorodesoxyglucose (FDG) in the detection of primary tumours in patients with metastases from CUP. Thirteen patients with lymph node metastases from cytologically verified CUP have undergone total body FDG PET which confirmed the possibility of lymph nodal lesion; all patients have also undergone conventional imaging with CT and/or MRI. The data obtained with the FDG-PET method have subsequently been confirmed both by the histopathological examination and by the clinical course of the disease. The current work aims at assessing and defining the effectiveness of the FDG-PET method during the diagnostic work-up of laterocervical metastasis from CUP conventionally examined with CT and/or MRI; based on our results, we recommend a flow-chart for the clinical-diagnostic management of the patient affected by laterocervical metastasis in the absence of known primary.
Similar content being viewed by others
References
Medini E, Medini AM, Lee CK, Gapany M, Levitt SH (1998) The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary. Am J Clin Oncol 21:121–125. doi:10.1097/00000421-199804000-00004
Jereczek-Fossa BA, Jassem J, Orecchia R (2004) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treatm Rev 30:153–164. doi:10.1016/j.ctrv.2003.10.001
Abruzzese JL, Abruzzese MC, Hess KR et al (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 6:1272–1280
Steinkamp HJ, Heim T, Zwicker BA et al (1992) The value of nuclear magnetic resonance tomography in tumor staging of laryngeal-hypopharyngeal cancer. HNO 40:339–345
Benchaud M, Lehmann W, Slosman DO, Becker M et al (1996) The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 116:332–335. doi:10.3109/00016489609137852
van de Wouw AJ, Jansen RLH, Speel EJM, Hillen HFP (2003) The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 14:191–196. doi:10.1093/annonc/mdg068
Million RR, Cassisi NJ, Mancuso AA (1994) The unknown primary. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer: a multidisciplinary approach, 2nd edn. Lippincott, PA, pp. 311–321
Sack MJ, Weber RS, Wienstien GS, Chalian AA et al (1998) Image guided fine needle aspiration of the head and neck: five years’ experience. Arch Otolaryngol Head Neck Surg 124:1155–1161
Courtois A, Foehrenbach H, Maszelin P, de Druille O, Garcia D et al (2001) La tomographie à émission de positons en oncologie ORL. Ann Otolaryngol Chir Cervicofac 118(4):254–260
van Veen SAJM, Balm AJM, Valdés Olmos RA, Hoefnagel CA, Hilgers FJM, Tan IB, Pamijier FA (2001) Occult primary tumors of the head and neck. Arch Otolaryngol Head Neck Surg 127:406–411
Bailet JW, Abemayor E, Jabour BA et al (1992) Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281–288
Bailet J, Sercrz J, Abemayor E, Anzai Y, Lufkin R, Hoh C (1995) The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 105:135–139. doi:10.1288/00005537-199502000-00004
Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Toso S, Barile C, Rampin Nibale O, Fanti S (2005) Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 32:589–592. doi:10.1007/s00259-004-1734-3
Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L (1999) 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 35:1076–1082. doi:10.1016/S0959-8049(99)00077-5
Minn H, Paul R, Anhonen A et al (1998) Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 29:1521–1525
Haberkorn U, Strauss LG, Reisser C, Haag D et al (1991) Glucose uptake perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 32:1548–1555
Rades D, Kuhnel G, Wildfang I, Borner AR, Schmoll HJ, Knapp W (2001) Localised disease in cancer of unknown primary: the value of positron emission tomography for individual therapeutic management. Ann Oncol 12:1605–1609. doi:10.1023/A:1013107732572
Fakhry N, Jacob T, Paris J, Barberet M, Mundler O, Giovanni A, Zanaret M (2006) Apport du TEP scanner au [18F]-FDG dans les adénopathies cervicales primitives. Ann Otolaryngol Chir Cervicofac 123:17–25. doi:10.1016/S0003-438X(06)76634-8
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Padovani, D., Aimoni, C., Zucchetta, P. et al. 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 266, 267–271 (2009). https://doi.org/10.1007/s00405-008-0733-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-008-0733-6